Genomic Signature Predicts Prostate Cancer Metastasis RiskGenomic Signature Predicts Prostate Cancer Metastasis Risk

A DNA signature obtained from biopsies from untreated prostate cancer patients can differentiate between patients at low or high risk for metastasis even when clinical predictive factors appear equal. Medscape Medical News
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news